Seamus Mulligan leads $20m funding at medtech Avectas
Drug delivery specialist aims to be key player as medicine turns to cell technology and personalised medicine to tackle cancers
Drug delivery specialist aims to be key player as medicine turns to cell technology and personalised medicine to tackle cancers
Drugmaker Teva and three distributors reached a settlement with two US counties over their alleged role in the opioid addiction crisis, just moments before the start a trial
Avectas has now raised $20m as it looks to unlock potential of personalised medicine
Cantillon: Indigenous firms Adapt, Chanelle and Novate show how to do business
Entrepreneur might turn attention to Maynooth University cancer therapy spinout
US opioid crisis helped growth of overdose rescue drug marketed by Adapt Pharma
Adapt Pharma’s Narcan spray used in the front line of opioid crisis in United States
Adapt Pharma sold to US group Emergent Biosolutions as US opioid crisis drives demand
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices